diazooxonorleucine has been researched along with Nausea in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lemberg, KM; Rais, R; Slusher, BS; Vornov, JJ | 1 |
| Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ; Sorensen, S; van Hazel, GA | 1 |
| Casper, E; Kemeny, N; Lynch, G | 1 |
| Casper, ES; Magill, GB; Sklaroff, RB; Young, CW | 1 |
1 review(s) available for diazooxonorleucine and Nausea
| Article | Year |
|---|---|
We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of
Topics: Animals; Antimetabolites, Antineoplastic; Diazooxonorleucine; Glutamine; Humans; Molecular Structure; Nausea; Neoplasms; Prodrugs; Vomiting | 2018 |
3 other study(ies) available for diazooxonorleucine and Nausea
| Article | Year |
|---|---|
A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Azo Compounds; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Rectal Neoplasms; Vomiting | 1983 |
Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Azo Compounds; Carcinoma; Colonic Neoplasms; Diazooxonorleucine; Drug Administration Schedule; Drug Evaluation; Humans; Middle Aged; Nausea; Rectal Neoplasms; Vomiting | 1982 |
Phase I study of 6-diazo-5-oxo-L-norleucine (DON).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Azo Compounds; Bone Marrow; Carcinoma, Squamous Cell; Diazooxonorleucine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 1980 |